作者:
Robbie,S.J. [1]
;
vonLeithner,P.L. [2]
;
Ju,M. [3]
;
Lange,C.A. [4]
;
King,A.G. [5]
;
Adamson,P. ;
Lee,D. ;
Sychterz,C. ;
Coffey,P. ;
Ng,Y.-S. ;
Bainbridge,J.W. ;
Shima,D.T.
作者单位:
Department of Genetics, University College London Institute of Ophthalmology, London, United Kingdom
[1]
Ophthiris Discovery Performance Unit, GlaxoSmithKline, Stevenage, United Kingdom
[2]
Department of Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, King of Prussia, PA, United
[3]
Safety Assessment Unit, GlaxoSmithKline, Stevenage, United Kingdom
[4]
Department of Ocular Biology and Therapeutics, University College London Institute of Ophthalmology
[5]
发布时间
2014-01-22